Skip to content

Clinical Study of Perioperative Sleep Disorders in Cardiac Surgery

Clinical Study of Perioperative Sleep Disorders in Cardiac Surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06778811
Enrollment
180
Registered
2025-01-16
Start date
2024-10-11
Completion date
2025-09-30
Last updated
2025-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Wake Disorders, Esketamine and the Quality of Recovery, Dexmedetomidine

Brief summary

The aim of this clinical trial is to understand the effects of dexmedetomidine and esketamine on postoperative sleep in patients undergoing cardiac surgery. The main questions it aims to answer are: Does dexmedetomidine or esketamine prevent the development of postoperative sleep disturbances? Which one works better? The researchers compared dexmedetomidine and esketamine with saline (a drug-free solvent) to see if dexmedetomidine and esketamine prevented the development of postoperative sleep disturbances. Participants will: 1. Intraoperative continuous infusion of dexmedetomidine, esketamine or saline until the end of surgery 2. Postoperative sleep was assessed on the first and third postoperative days using a sleep rating scale

Interventions

DRUGIntraoperative infusion of dexmedetomidine

Intraoperative infusion of 0.3ug/kg/h dexmedetomidine

DRUGIntraoperative infusion of esketamine

Intraoperative infusion of 0.3mg/kg/h esketamine

Intraoperative infusion of equal volumes of saline

Sponsors

Nanjing First Hospital, Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. ASA class II-III, NYHA class I-III, EF ≥ 50% 2. Intended to perform cardiac surgery under extracorporeal circulation

Exclusion criteria

1. Patients undergoing second heart surgery 2. Patients with mental retardation, deafness, or other conditions that interfere with normal communication 3. Previous neurological or psychiatric disorders 4. Patients with a history of sleep disorders 5. Alcoholics, drug addicts, or psychotropic substance abusers 6. Significant hepatic or renal dysfunction affecting drug metabolism 7. Contraindication to the use of dexmedetomidine or esketamine.

Design outcomes

Primary

MeasureTime frameDescription
Sleep Quality1, 3, 7days after surgeryAssessment of sleep quality by the Athens Insomnia Scale (AIS) and smart wearable device

Secondary

MeasureTime frameDescription
postoperative pain24 hours and 48 hours after surgeryAssessment of postoperative pain levels by Visual Analogue Scale(VAS),from 0 to 10, Higher scores mean more severe pain,VAS\>4 means positive.
Record postoperative analgesic medications used and the amount used for postoperative pain24 hours and 48 hours after surgeryRecord postoperative analgesic medications used and the amount used
anxiety and depression assessment1,3 days after surgeryAssessment of anxiety and depression levels by Hospital anxiety and depression scale (HADS),0-7 is negative; 8-10 is mild; 11-14 is moderate; 15-21 is severe.
Postoperative complications48 hours after surgeryincluding nausea and vomiting, dizziness, itching, nightmares and so on.
Postoperative deliriumfrom 1 day to 7 days after surgeryAssessment of Postoperative delirium by Confusion Assessment Method (CAM),scores \> 21 is positive.

Countries

China

Contacts

Primary ContactKuang xueyi
kxy809707496@126.com86+18651908072
Backup Contacthongwei shi
mdshw@163.com86+18951670892

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026